Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2017) 50 CC03 | DOI: 10.1530/endoabs.50.CC03

SFEBES2017 Featured Clinical Cases Featured Clinical Cases (10 abstracts)

A novel variant in the androgen receptor gene causing familial mild androgen insensitivity syndrome

Donato Iacovazzo 1 , Ajith Kumar 2 , Stephen Abbs 3 , Andrew Solomon 4 , Márta Korbonits 1 & Maralyn Druce 1

1Centre for Endocrinology, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom; 2Clinical Genetics Unit, North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, United Kingdom; 3East Anglian Regional Genetics Laboratory, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; 4Diabetes and Endocrinology Unit, East and North Hertfordshire NHS Trust, Stevenage, United Kingdom.

Introduction: Androgen insensitivity syndrome (AIS) is a heterogeneous condition. At the milder end of the clinical spectrum, patients with mild AIS (MAIS) are phenotypically male, and may present with infertility, either isolated or associated with gynaecomastia or signs of mild undervirilization. Most cases of complete and approximately 25% of partial AIS patients harbour mutations in the androgen receptor (AR) gene. Over 1,000 pathogenic variants have been described, but only approximately 40 of these are reported to cause MAIS.

Case report: A 30 year-old male with a history of infertility was referred to us following the finding of severe oligozoospermia and a raised testosterone. He had scant facial and body hair and gynaecomastia since puberty. His brother (who was also found to have oligozoospermia), and a male cousin from his mother’s side had similar physical appearance. On examination, testicles were of normal volume (15 ml) and penile length was normal. Biochemistry showed raised testosterone (43 nmol/l, normal 8.6–29), raised LH (12 U/l, normal 1.7–8.6) and normal FSH (6 U/l, normal 4.6–12.5), with an increased androgen sensitivity index (516 U*nmol/l2, normal 14.6–249.4). In view of these results and the putative family history, MAIS due to an AR mutation was suspected. Sequencing of the AR gene showed a novel hemizygous six base pair duplication resulting in the duplication of two amino acids (p.Leu56_Leu57dup). The same variant was identified in his brother and cousin. While this variant has not been previously reported, duplication of Leu57 was described in a subject with MAIS, further supporting the pathogenic role of the p.Leu56_Leu57dup variant.

Conclusion: We report a case of familial MAIS due to a novel, likely pathogenic variant in the AR gene. Considering its clinical presentation, MAIS is an underdiagnosed condition. Evidence of raised testosterone and a positive family history may guide the diagnosis and help identifying the causative genetic abnormality.

Volume 50

Society for Endocrinology BES 2017

Harrogate, UK
06 Nov 2017 - 08 Nov 2017

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.